Mortality risk among individuals who smoke opioids compared with those who inject: A propensity score‐matched cohort analysis of United States national treatment data
Addiction · 2025-05 · 120 (5) · 1040-1045
DOI: 10.1111/add.16740 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Addiction, online erschienen am 22.01.2025. Verfasst von George Karandinos und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA, USA. Hauptthemen laut MEDLINE: Opioid-Related Disorders, Substance Abuse, Intravenous, Analgesics, Opioid. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, National Institute on Drug Abuse.
Abstract (Originalsprache)
Background and Aims Opioid smoking is becoming more common in the United States. The aim of this analysis was to estimate relative mortality risk among those who primarily smoke opioids compared with those who inject.
Design
Retrospective propensity score‐matched cohort analysis.
Setting
2006–2021 US treatment episode data from SAMHSA TEDS‐D.
Participants
We matched 287 481 individuals in a substance use treatment program reporting smoking opioids as their primary substance use to an equal weighted number of individuals in a substance use treatment program reporting injecting opioids as their primary substance use. The majority of individuals reporting smoking were male (62.6%), 21–29 years old (47.9%), white (65.7%), independently housed (54.3%) and in the West Census Region (70.3%). Cohort characteristics were closely balanced after matching.
Measurements
The outcome of interest was death during a treatment episode. Variables used for matching were year, opioid category, gender, race/ethnicity, age category, census region, housing status, employment status, number of prior treatment admissions, variables associated with opioid use severity (opioid use frequency, treatment setting intensity, age at first opioid use, use of medication‐assisted treatment) and other reported substance use (methamphetamine, alcohol, benzodiazepines, cocaine).
Findings
The mortality rate was 6.5 [95% confidence interval (CI) = 5.9–7.1] per 1000 person‐years in the smoking cohort and 9.7 (95% CI = 8.8–10.8) per 1000 person‐years in the injection cohort, with a mortality rate ratio of 0.67 (95% CI = 0.58–0.77).
Conclusions
Among individuals in substance use treatment in the United States, those who usually smoke opioids appear to have a lower all‐cause mortality risk than those who usually inject.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA, USA.
- Harvard Medical School, Boston, MA, USA.
- University of Maryland Baltimore, Baltimore, MD, USA.
- Family and Community Medicine, University of California San Francisco, San Francisco, CA, USA.
ORCID-Profile: George Karandinos
Förderung
- NIDA NIH HHS
- National Institute on Drug Abuse
Zitieren
APA
Karandinos, G., Unick, J., & Ciccarone, D. (2025). Mortality risk among individuals who smoke opioids compared with those who inject: A propensity score‐matched cohort analysis of United States national treatment data. Addiction, 120(5), 1040-1045. https://doi.org/10.1111/add.16740
Vancouver
Karandinos G, Unick J, Ciccarone D. Mortality risk among individuals who smoke opioids compared with those who inject: A propensity score‐matched cohort analysis of United States national treatment data. Addiction. 2025;120(5):1040-1045. doi:10.1111/add.16740
BibTeX
@article{Karandinos2025,
author = {Karandinos, George and Unick, Jay and Ciccarone, Daniel},
title = {Mortality risk among individuals who smoke opioids compared with those who inject: A propensity score‐matched cohort analysis of United States national treatment data},
journal = {Addiction},
year = {2025},
volume = {120},
number = {5},
pages = {1040--1045},
doi = {10.1111/add.16740}
}
EUVIMED